North America held a leading position in the extracellular matrix market, accounting for 38.6% of the global market share in 2021. The region's strong position is supported by advanced healthcare infrastructure, increasing adoption of regenerative medicine, and rising demand for innovative solutions in tissue repair and reconstruction. The growing incidence of cardiovascular disorders,...

The US extracellular matrix market represents a significant share of the North American market and is projected to grow at a CAGR of 7.6% during the forecast period. Market expansion in the US is associated with the rising prevalence of cardiovascular diseases, trauma, wounds, and surgical conditions, together with increasing utilization of advanced tissue-repair technologies. According to The...